OxThera stock price, funding rounds, valuation and financials

OxThera has raised $53.30 m in total funding. OxThera annual revenue was kr11.01 m in FY 2015

KR11 M

OxThera Revenue FY, 2015
OxThera Revenue growth (FY, 2014 - FY, 2015), %25%
OxThera Net income (FY, 2015)-37.8 M
OxThera EBITDA (FY, 2015)-34.7 M
OxThera EBIT (FY, 2015)-34.8 M
OxThera Cash, 31-Dec-20158.9 M

OxThera Funding

Summary Metrics

OxThera total Funding

$53.3 m

OxThera investors

OxThera Income Statement

Annual

SEKFY, 2013FY, 2014FY, 2015

Revenue

3.8m8.8m11.0m

Revenue growth, %

131%25%

Sales and marketing expense

64.2m37.8m

General and administrative expense

4.8m7.7m7.8m

Operating expense total

4.8m72.1m45.7m

Depreciation and amortization

134.2k100.3k

EBITDA

(33.6m)(63.3m)(34.7m)

EBITDA margin, %

(880%)(720%)(315%)

EBIT

(3.4m)(63.5m)(34.8m)

EBIT margin, %

(88%)(721%)(316%)

Net Income

(33.5m)(69.3m)(37.8m)

OxThera Balance Sheet

Annual

SEKY, 2013Y, 2014Y, 2015

Cash

25.3m8.9m

Total Assets

38.6m35.1m15.4m

Total Debt

25.6m53.2m

Total Liabilities

13.0m42.0m57.1m

OxThera Ratios

SEKFY, 2013